CEA Rapid Test Kit - Vitrosens Biotechnology
CEA Rapid Test Kit

CEA Rapid Test Kit

Test kit qualitatively detects tumor marker Carcinoembryonic Antigen (CEA) in human serum, plasma, and whole blood samples.

Advantages

–  Aids the diagnosis of several types of cancer including colorectal, pancreatic,
stomach, breast, lung, certain forms of thyroid and ovarian cancer.
–  Supports the screening of cancer patients
–  High rates of sensitivity and accuracy
–  Simple procedure and visual interpretation

Box Content

– Test Cassette
– Lancette(Optional)
– Dropper
– Sample Diluent
– User Manual

Specification

Intended use Detection of SARS-CoV-2 antigen
Storage 2-30℃ / 35.6-86℉
Specimen type Nasal swab
Time to result 15-30 minutes
Shelf life 24 months
Sensitivity 93.1%
Specificity 100.0%

Video

.embed-container { position: relative; padding-bottom: 56.25%; height: 0; overflow: hidden; max-width: 100%; } .embed-container iframe, .embed-container object, .embed-container embed { position: absolute; top: 0; left: 0; width: 100%; height: 100%; }

Order Information

 Ref. No.
Target
Specimen
Kit Size
Certification

VMD45

CEA

S/P/WB

25  T

Saliva Antigen Test Kit

S:Serum, P:Plasma, WB:Whole Blood

footer-logo

Vitrosens Biotechnology is a high-tech company in Turkey founded for the development, manufacture, and delivery of in vitro diagnostic devices (IVD) to the world.
Follow USVITROSENS on Social Media
For our updated news and products follow us on social media.

vitrosens logo new

Vitrosens Biotechnology is a high-tech company in Turkey founded for the development, manufacture, and delivery of in vitro diagnostic devices (IVD) to the world.
vitrosens.com
Human Health
Animal Health
Follow USVITROSENS on Social Media
For our updated news and products follow us on social media.